2025-05-22 06:01:36 pm | Source: reuters
India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.
The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Arattai`s engineering has `lot of depth`: Zoho`s Sri...
India, EU eye trade deal in three months amid US tar...
NaMo Semiconductor Lab to strengthen India`s chip de...
How to Use Technology to Manage and Grow Your Money
Indra Nooyi ? Leadership Lessons from PepsiCo`s Form...
Smart Security Cameras ? The Modern Way to Keep Your...
The Timeless Elegance of 1940s Vintage Fashion
WPAC 2025: Unbeaten Hannah Cockroft powers her way t...
Rashami Desai on fitness journey: Down 9 Kgs, having...
Soha Ali Khan`s birthday was all about `cake, calm a...
